In humans, FOXL2 heterozygous mutations are responsible for the blepharophimosis-ptosis-epicanthus inversus syndrome (BPES), characterized by facial malformations often associated with primary ovarian insufficiency (POI) (Crisponi et al., 2001). Here, FOXL2 is linked to blepharophimosis, ptosis, and epicanthus inversus syndrome.